CoChat

Cost‐Effectiveness of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea‐Hypopnea in British Columbia

Open access
Tan, MCY, Ayas, NT, Mulgrew, A, Cortes, L, FitzGerald, JM, Fleetham, JA, Schulzer, M, Ryan, CF, Ghaeli, R, Cooperx, P, Marra, CA · 2008 · Canadian Respiratory Journal
Cited by 46

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Obstructive sleep apnea‐hypopnea (OSAH) is a common disorder characterized by recurrent collapse of the upper airway during sleep. Patients experience a reduced quality of life and an increased risk of motor vehicle crashes (MVCs). Continuous positive airway pressure (CPAP), which is the first‐line therapy for OSAH, improves sleepiness, vigilance and quality of life. OBJECTIVE: To assess the cost‐effectiveness of CPAP therapy versus no treatment for OSAH patients who are drivers. METHODS: A Markov decision analytical model with a five‐year time horizon was used. The study population consisted of male and female patients, between 30 and 59 years of age, who were newly diagnosed with moderate to severe OSAH. The model evaluated the cost‐effectiveness of CPAP therapy in reducing rates of MVCs and improving quality of life. Utility values were obtained from previously published studies. Rates of MVCs under the CPAP and no CPAP scenarios were calculated from Insurance Corporation of British Columbia data and a systematic review of published studies. MVCs, equipment and physician costs were obtained from the British Columbia Medical Association, published cost‐of‐illness studies and the price lists of established vendors of CPAP equipment in British Columbia. Findings were examined from the perspectives of a third‐party payer and society. RESULTS: From the third‐party payer perspective, CPAP therapy was more effective but more costly than no CPAP (incremental cost‐effectiveness ratio [ICER] of $3,626 per quality‐adjusted life year). From the societal perspective, the ICER was similar ($2,979 per quality‐adjusted life year). The ICER was most dependent on preference elicitation method used to obtain utility values, varying almost sixfold under alternative assumptions from the base‐case analysis. CONCLUSION: After considering costs and impact on quality of life, as well as the risk of MVCs in individuals with OSAH, CPAP therapy for OSAH patients is a highly efficient use of health care resources. Provincial governments who do not provide funding for CPAP therapy should reconsider.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2008/719231

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Metadata

Authors
Tan, M., Ayas, N., Mulgrew, A., Cortes, L., FitzGerald, J., Fleetham, J., Schulzer, M., Ryan, C., Ghaeli, R., Cooperx, P., & Marra, C.
Venue
Canadian Respiratory Journal
Publisher
Wiley
Published
2008-01
Volume
15
Issue
3
Pages
159-165
ISSN
  • 1198-2241 (ISSN-L)
  • 1916-7245
OpenAlex
W44727445
Cited by
46
References
4
FWCI
1.41
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost‐Effectiveness of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea‐Hypopnea in British Columbia. https://app.cochat.ai/papers/10.1155/2008/719231
The paper
Tan, M., Ayas, N., Mulgrew, A., Cortes, L., FitzGerald, J., Fleetham, J., Schulzer, M., Ryan, C., Ghaeli, R., Cooperx, P., & Marra, C. (2008). Cost‐Effectiveness of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea‐Hypopnea in British Columbia. Canadian Respiratory Journal. https://doi.org/10.1155/2008/719231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.